1. Share Prices

  2. Gsk PLC (GSK)

1,778.50p-14.50 (-0.82%)07 Nov 2025, 16:02
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Gsk PLC Fundamentals

Company NameGsk PLCLast Updated2025-11-07
IndustryDrug Manufacturers - GeneralSectorHealthcare
Shares in Issue4.019 bnMarket Cap£70.98 bn
PE Ratio13.37Dividend per Share£0.61
Dividend Yield3.54Dividend Cover1.02
EPS£0.62EPS Growth (%)-0.30
PEG0.41DPS Growth (%)0.0942
Debt Ratio0.2894Debt Equity Ratio0.9223
Asset Equity Ratio3.8940Cash Equity Ratio0.2099
Quick Ratio0.5270Current Ratio0.84
Price To Book Value4.4267ROCE0

Gsk PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total
Interim2025-11-132026-01-08GBP0.1600
Interim2025-08-142025-10-09GBP0.1600
Interim2025-05-152025-07-10GBP0.1600
Prelim2025-02-202025-04-10GBP0.1600
Interim2024-11-142025-01-09GBP0.1500
Interim2024-08-152024-10-10GBP0.1500
Interim2024-05-162024-07-11GBP0.1500
Prelim2024-02-222024-04-11GBP0.1600
Interim2023-11-162024-01-11GBP0.1400
Interim2023-08-172023-10-12GBP0.1400
Interim2023-05-182023-07-13GBP0.1400
Prelim2023-02-232023-04-13GBP0.1375
Interim2022-11-172023-01-12GBP0.1375

Gsk PLC Company Financials

Assets202420232022
Tangible Assets£10.07 bn£9.96 bn£9.62 bn
Intangible Assets£22.50 bn£21.58 bn£21.36 bn
Investments£1.23 bn£1.22 bn£1.57 bn
Total Fixed Assets£42.47 bn£40.36 bn£39.38 bn
Stocks£5.67 bn£5.50 bn£5.15 bn
Debtors£6.00 bn£6.46 bn£6.22 bn
Cash & Equivalents£3.71 bn£4.99 bn£7.68 bn
Other Assets£8.66 bn£7.61 bn£6.82 bn
Total Assets£59.46 bn£59.01 bn£60.15 bn
Liabilities202420232022
Creditors within 1 year£21.70 bn£21.07 bn£22.81 bn
Creditors after 1 year£24.68 bn£25.14 bn£27.24 bn
Other Liabilities000
Total Liabilities£46.38 bn£46.21 bn£50.05 bn
Net assets£13.09 bn£12.79 bn£10.10 bn
Equity202420232022
Called up share capital£1.35 bn£1.35 bn£1.35 bn
Share Premium£3.47 bn£3.45 bn£3.44 bn
Profit / Loss£3.48 bn£6.06 bn£5.63 bn
Other Equity£13.67 bn£13.35 bn£10.60 bn
Preference & Minorities-£585.00 m-£552.00 m-£502.00 m
Total Capital Employed£13.09 bn£12.79 bn£10.10 bn
Ratios202420232022
Debt Ratio£0.52£0.53£0.62
Debt-to-Equity£1.07£1.14£1.61
Assets / Equity3.89403.89403.8940
Cash / Equity0.20990.20990.2099
EPS£0.94£1.33£1.17
Cash Flow202420232022
Cash from operating activities£6.55 bn£6.77 bn£7.40 bn
Cashflow before financing£1.83 bn£1.13 bn£8.23 bn
Increase in Cash£599.00 m-£468.00 m-£546.00 m
Income202420232022
Turnover£31.38 bn£30.33 bn£29.32 bn
Cost of sales£9.05 bn£8.56 bn£9.55 bn
Gross Profit£22.33 bn£21.76 bn£19.77 bn
Operating Profit£4.02 bn£6.75 bn£6.43 bn
Pre-Tax profit£3.48 bn£6.06 bn£5.63 bn

Gsk PLC Company Background

SectorHealthcare
ActivitiesIn the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Latest Interim Date30 Jul 2025
Latest Fiscal Year End Date5 Feb 2025

Gsk PLC Directors

AppointedNamePosition
2017-03-14Sir Deryck MaughanNon-Executive Director
2009-04-01Sir Ian Maurice Gray ProsserNon-Executive Director
2012-04-02Mr. James R. MurdochIndependent Non-Executive Director
2011-08-09Dr. Jean-Pierre Garnier, PhDChief Executive Officer and Director
2023-03-10Ms. Lynn Laverty ElsenhansNon-Executive Director
2017-03-14Dr. Stephanie A. Burns, PhDNon-Executive Director
2025-10-16Dr. Hal V BarronNon-Executive Director
2024-03-01Ms. Judy C. LewentNon-Executive Director
2023-03-10Dr. Laurie H. GlimcherNon-Executive Director
2015-05-07Sir Christopher Charles GentNon-Executive Director,Chairman
2018-03-13Mr. Andrew P. WittyExecutive Director,Chief Executive Officer
2008-08-04Mr. Chris ViehbacherExecutive Director
2013-05-03Sir Crispin H. DavisNon-Executive Director
2017-03-14Dr. Daniel Podolsky, M.D.Non-Executive Director
2017-03-14Mr. Gerardus Johannes Wijers Non-Executive Director
2025-06-23Sir Jonathan Richard Symonds CBENon-Executive Director,Chairman
2011-10-20Mr. Julian HeslopExecutive Director,Chief Financial Officer
2012-09-28Mr. Lawrence CulpNon-Executive Director
2023-03-10Mr. Manvinder Singh BangaNon-Executive Director,Senior Independent Director
2018-03-13Dr. Moncef M. Slaoui, PhDExecutive Director,Chairman, Global RandD and Vaccines
2022-03-04Sir Philip Roy Hampton KBNon-Executive Director,Chairman
2015-05-07Mr. Tom De SwaanNon-Executive Director
2024-05-08Mr. Urs RohnerNon-Executive Director
2024-07-15Dr. Dame Vivienne CoxNon-Executive Director
2014-07-23Sir Robert Peter WilsonNon-Executive Director
2018-05-04Professor Sir. Roy AndersonNon-Executive Independent Director
2025-10-13Mr. Charles A. BancroftNon-Executive Director,Senior Independent Director
2017-03-15Ms. Stacey CartwrightNon-Executive Independent Director
2016-03-17Dr. Ronaldo Hermann SchmitzNon-Executive Director
2025-10-15Mrs. Victoria Anne WhyteCompany Secretary
2025-09-22Ms. Wendy BeckerNon-Executive Director
2025-10-13Dr. Vishal SikkaNon-Executive Director
2024-03-01Mr. Iain James MackayExecutive Director,Chief Financial Officer
2020-03-06Mr. Simon P Dingemans Executive Director,Chief Financial Officer
2018-03-28Mr. Patrick VallanceExecutive Director
2025-10-15Dame Emma N. WalmsleyExecutive Director,Chief Executive Officer
2015-05-07Ms. Jing UlrichNon-Executive Director
2025-10-15Ms. Julie BrownExecutive Director,Chief Financial Officer
2025-05-07Dr. Jesse Goodman, M.D.,M.P.H.Non-Executive Director
2025-10-13Ms. Elizabeth McKee AndersonNon-Executive Director
2025-10-13Dr. Anne Beal, M.D.,M.P.H.Non-Executive Director
2025-10-13Dr. Harry C DietzNon-Executive Director
2025-10-13Dr. Jeannie LeeNon-Executive Director
2025-05-01Dr. Gavin ScreatonNon-Executive Director

Gsk PLC Contact Details

Company NameGSK PLC
Address980 Great West Road, Brentford, TW8 9GS
Telephone+44 2080475000
Websitehttps://www.gsk.com

Gsk PLC Advisors

AuditorDeloitte LLP
Phone+44 2079363000
Fax+44 2075831198
Financial PR AdviserBrunswick Group LLP
Phone+44 2074045959
Fax+44 2078312823
SolicitorAllen & Overy LLP
Phone+44 2030880000
Fax+44 207339999
BankNational Westminster Bank PLC
RegistrarEquiniti Limited
Remuneration ConsultantWillis Towers Watson
Phone+44 2071702000
Fax+44 2071702222
SolicitorSlaughter and May
Phone+44 2076001200
Fax+44 2070905000
BankHSBC Bank PLC
StockbrokerCiti
Phone+44 2079864000
Fax+44 2079862266
AuditorPricewaterhouseCoopers LLP
Phone+44 2075835000
Fax+44 2078224652
SolicitorCleary Gottlieb Steen & Hamilton
Phone+1 212 225-2000
Fax+1 212 225-3999
AuditorCoopers & Lybrand
AuditorDeloitte

Most Read

Receive our
daily news email

Subscribe to the latest investing news by entering your email address below

You can opt out at any time.

For five days a week you will get

  • The latest company news
  • Insight into investment trends
  • Round-up of director's buys and sells
  • Articles from Shares magazine
Sharesmagazine cover

Plus more useful investment content and occasional promotional offers.

Shares Magazine Latest Issue Cover
Latest Issue:
25 Sep 2025

Market Overview

UK 350 Risers and Fallers

Risers

CompanyPrice% Chg
Itv PLC78.6516.17
Oxford Nanopore Technologies PLC142.006.21
Jtc PLC1,354.004.80
Hikma Pharmaceuticals PLC1,592.004.60
Coca-Cola Europacific Partners PLC6,940.003.43
Wpp PLC277.702.74